DarioHealth Corp. 8-K Filing: Key Insights & Financial Updates - December 2024

Based on the provided XML section of the financial report, here are the key insights and information extracted:

1. Company Information:

• Name: DarioHealth Corp.
• CIK: 0001533998
• Address: 122 W 57th St #33B, New York, NY 10019
• Phone Number: 972-4-770-6377
• Country: United States

2. SEC Filing:

• Filing Type: 8-K (a report of unscheduled material events or corporate changes)
• Filing Date: December 18, 2024
• SEC Central Index Key (CIK): 0001533998
• IRS Employer Identification Number: 45-2973162

3. Stock Information:

• Security Type: Common Stock
• Par Value: $0.0001 per share
• Ticker Symbol: DRIO
• Exchange: NASDAQ

4. Financial Measurement:

• The report mentions multiple measurement units including USD (U.S. Dollars), Shares, and USD per Share.
• The specific context indicates the report is relevant for the date December 18, 2024.

5. Document Structure:

• The document is formatted in XBRL (eXtensible Business Reporting Language), which is commonly used for financial reporting to enhance transparency and facilitate data exchange.

Insights:

• The filing is a significant event for DarioHealth Corp., indicating that the company may have experienced a material event that warranted disclosure.
• The common stock's low par value suggests a potentially startup or early-stage company, as companies often maintain low par values for flexibility in issuing shares.
• The use of the 8-K filing indicates that DarioHealth is actively communicating with investors and regulators, which can be a positive sign regarding corporate governance and transparency.

This information can be critical for investors, analysts, and stakeholders assessing the company's activities and financial health as of the specified date.